EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management

Xiaoyan Dong, Yaoyu Suo, Jie Yu, Feifei Yu, Feng Li, Judun Zheng, Guizhong Li, Shengchao Ma, Yinju Hao, Huiping Zhang, Bin Liu iD, Yideng Jiang

ACS Nano · 22.07.2025 · 19 (28) · 25628-25644

DOI: 10.1021/acsnano.5c00216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.07.2025. Verfasst von Xiaoyan Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Nanoparticles, Biomimetic Materials. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Ningxia, National Natural Science Foundation of China, Ningxia Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMacrophagesNanoparticlesBiomimetic MaterialsLipid MetabolismAnimalsMicePhenotypeMice, Inbred C57BLRAW 264.7 CellsRosuvastatin CalciumPlaque, AtheroscleroticMaleHyaluronic AcidBiomimeticsApolipoproteins EHumans

Stichwörter der Autor:innen

antioxidant and anti-inflammatoryatherosclerosisbiomimetic nanoparticleshydroxysafflor yellow A and rosuvastatinlipid metabolismphenotype of macrophages

Substanzen

Rosuvastatin CalciumHyaluronic AcidApolipoproteins E

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
  • NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan 750004, China.
  • Ningxia Key Laboratory of Vascular Injury and Repair Research, Yinchuan 750004, China.
  • Medical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
  • Dermatology Hospital Southern Medical University, Guangzhou 510091, P. R. China.
  • Department of Medical Genetics, Maternal and Child Health Hospital of Hunan Province, Changsha 410008, China.

ORCID-Profile: Bin Liu

Förderung

  • Key Research and Development Program of Ningxia
  • National Natural Science Foundation of China
  • Ningxia Medical University
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Dong, X., Suo, Y., Yu, J., Yu, F., Li, F., Zheng, J., Li, G., Ma, S., Hao, Y., Zhang, H., Liu, B., & Jiang, Y. (2025). Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management. ACS Nano, 19(28), 25628-25644. https://doi.org/10.1021/acsnano.5c00216

Vancouver

Dong X, Suo Y, Yu J, Yu F, Li F, Zheng J, et al. Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management. ACS Nano. 2025;19(28):25628-25644. doi:10.1021/acsnano.5c00216

BibTeX
@article{Dong2025,
  author = {Dong, Xiaoyan and Suo, Yaoyu and Yu, Jie and Yu, Feifei and Li, Feng and Zheng, Judun and Li, Guizhong and Ma, Shengchao and Hao, Yinju and Zhang, Huiping and Liu, Bin and Jiang, Yideng},
  title = {Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {28},
  pages = {25628--25644},
  doi = {10.1021/acsnano.5c00216}
}
Kostenlos starten →